Pathologist, Bordeaux University Hospital. Special interest in renal and transplant pathology.
Bordeaux, France
Joined September 2022
- Tweets60
- Following59
- Followers55
- Likes196
Bertrand Chauveau retweeted
The Banff 2024 meeting report is official! Link to the article (free access) is below- now get ready for the next Banff meeting, October 5-9, 2026, in beautiful Banff, Alberta, Canada!!
authors.elsevier.com/sd/arti… @Renalpathsoc #renalpath
Bertrand Chauveau retweeted
How many gene transcripts do you actually need to diagnose rejection phenotypes after kidney transplantation?
In our latest study in @KIReports, we found that the answer is surprisingly low!
kireports.org/article/S2468-…
1/6
Bertrand Chauveau retweeted
🧬Excited to share our new paper in @amjtransplant
“Molecular diagnosis of kidney allograft rejection using the B-HOT gene panel”
amjtransplant.org/article/S1…
#MolecularDiagnostics #Transplantation
Bertrand Chauveau retweeted
Evolving the Banff Classification for Kidney Allograft Rejection. This review paper by @_B_Chauveau et al. reports that innovations are reshaping rejection diagnostics! #Transplantation #KidneyTransplant #Transplantation #TXPforAll tinyurl.com/zh6m6wh6
Bertrand Chauveau retweeted
We now have a mass spectrometry test available for membranous nephropathy (MN) antigens.
Started in 2017 with no lab/funding (& still no lab/major funding)-one at a time-we were able to discover majority of MN antigens.
It was an idea that worked out.
news.mayocliniclabs.com/2025…
Bertrand Chauveau retweeted
Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. nej.md/4hiFoyJ
#KidneyWk
ALT A Sankey diagram of 4350 kidney-allograft biopsy specimens from patients with a diagnosis related to kidney-allograft rejection according to the 2022 Banff Classification of Renal Allograft Pathology.
Bertrand Chauveau retweeted
Dive into the #HORUS_CMV project with @hKminski, sharing insights on the team's efforts to understand #CMV's impact on transplant patients. Learn how they’re identifying signatures for personalised care to improve patient outcomes.
Watch the full video: horus-project.eu
Bertrand Chauveau retweeted
Glad to share our @EUTRAIN_project paper published in @Kidney_Int! 🙌
🙏 to the amazing #consortium behind this #biomarker validation study funded by @EU_Commission @HorizonEU 🇪🇺
@AlexandreLoupy C. Lefaucheur @ParisTxGroup @ESOTtransplant @ttsorg
kidney-international.org/art…
Bertrand Chauveau retweeted
Unveiling glomerular gold in oxalate nephropathy - Kidney International kidney-international.org/art…
Bertrand Chauveau retweeted
⚠️Happy to share our preliminary results on Imlifidase together with the French transplant community. 🙏🏻 @KamarNassim @dommibertrand @CaillardSophie @SFTfrancophone @SFTJuniors
More to come in 2025 🚨
kireports.org/article/S2468-…
Male in his 80’s. Waldenström (no TTT). IgM kappa 10g/L
CKD with SCr 1.86 mg/dl. Prot 0.19 g/g
FFPE: ischemic glomeruli, stripped fibrosis 65% & >=cv2
Frozen: granular IgM kappa deposits in intimal fibrosis of an arcuate artery. No other deposits
1/2
#AskRenalPath
@AskRenalPath
ALT Masson's trichrome (FFPE)
ALT HES (frozen)
Congo red -.
EM: not available
What should I call this? Any advices? 🙏
2/2
#AskRenalPath
@AskRenalPath
@Tiff_Caza
@JZRenalPath
@MRabant
@CandiceRoufosse
@Ijeb
@ChangUCanSpare
ALT IgM
ALT Kappa
ALT Lambda
ALT HES (frozen)
Bertrand Chauveau retweeted
More on “atypical anti-GBM disease”! Worldwide collaborative by B Chauveau et al published in @AJKDonline doi.org/10.1053/j.ajkd.2023.… also see my commentary “Anti–GBM Disease: Broadening the Spectrum” doi.org/10.1053/j.ajkd.2024.… #renalpath @Renalpathsoc @MayoClinicNeph @MayoClinicPath
Bertrand Chauveau retweeted
Our study on post-transplant TMA is out! TMA is mostly driven by AMR and CNI toxicity but often due to multiple factors, with higher rates of complement pathogenic variants, and associated with a poor prognosis.
Original Article by Dessaix et al, "De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury"
doi.org/10.1016/j.ajt.2024.0…
A nice collaborative work from the French Nephropathology Group!
Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group
bit.ly/3RJk3mf
@_B_Chauveau @Ijeb @MorelAntoine9 @stephenmcadoo @nivallet @virginieroyal @DemoulinNathal2 @alexhertig @CandiceRoufosse @karine_renaudin @MRabant
Bertrand Chauveau retweeted
Finally, the Banff 2022 Meeting Report and Workplan manuscripts underwent standard peer review by @amjtransplant, before being accepted and published.
Importantly, it was decided that the Banff Meeting Report manuscript(s) are made Gold Open Access.
Renal transplant. PVN in July => IS minimization.
Currently AKI with anuria and biological TMA.
Bx: diffuse glomerular TMA, g1 ptc1 v1
Any ideas what these interstitial dots are?
Immune cells do not seem to bother about it; not the aspect of Russel bodies to me.
#askrenalpath
No immune deposits by IF but also present in the frozen sample. Any ideas? 🙏
#AskRenalPath @AskRenalPath @Tiff_Caza @JZRenalPath @MRabant @CandiceRoufosse @Ijeb